Nur Olgun

1.5k total citations
117 papers, 1.0k citations indexed

About

Nur Olgun is a scholar working on Neurology, Molecular Biology and Oncology. According to data from OpenAlex, Nur Olgun has authored 117 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Neurology, 34 papers in Molecular Biology and 23 papers in Oncology. Recurrent topics in Nur Olgun's work include Neuroblastoma Research and Treatments (33 papers), Cancer therapeutics and mechanisms (12 papers) and Cancer, Hypoxia, and Metabolism (11 papers). Nur Olgun is often cited by papers focused on Neuroblastoma Research and Treatments (33 papers), Cancer therapeutics and mechanisms (12 papers) and Cancer, Hypoxia, and Metabolism (11 papers). Nur Olgun collaborates with scholars based in Türkiye, United States and Colombia. Nur Olgun's co-authors include Kamer Mutafoğlu, Safiye Aktaş, Zekiye Altun, Hale Ören, Faik Sarıalioğlu, Hülya Ellıdokuz, Erdener Özer, Yeşim Aydınok, Gülçin Özalp Gerçeker and Murat Bektaş and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Nur Olgun

105 papers receiving 981 citations

Peers

Nur Olgun
Choong Hyun Kim South Korea
Şeyda Erdoğan Türkiye
Karim Burkhardt Switzerland
Eelke M. Bos Netherlands
Indraneel Banerjee United Kingdom
Mario Castellucci Italy
Maurizio Guida Italy
Louisa Ho Canada
Kálmán Kovács Hungary
Moon Kyu Kim South Korea
Choong Hyun Kim South Korea
Nur Olgun
Citations per year, relative to Nur Olgun Nur Olgun (= 1×) peers Choong Hyun Kim

Countries citing papers authored by Nur Olgun

Since Specialization
Citations

This map shows the geographic impact of Nur Olgun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nur Olgun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nur Olgun more than expected).

Fields of papers citing papers by Nur Olgun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nur Olgun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nur Olgun. The network helps show where Nur Olgun may publish in the future.

Co-authorship network of co-authors of Nur Olgun

This figure shows the co-authorship network connecting the top 25 collaborators of Nur Olgun. A scholar is included among the top collaborators of Nur Olgun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nur Olgun. Nur Olgun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Aktaş, Safiye, et al.. (2023). Identification of ALK Mutation in Neuroblastoma on the Point of Molecular Heterogeneity. Technology in Cancer Research & Treatment. 22. 2223953026–2223953026.
4.
İnce, Dilek, et al.. (2023). Pediatric paravertebral tumors: analysis of 96 patients. Child s Nervous System. 40(1). 123–133.
5.
Aktaş, Safiye, et al.. (2023). Unraveling the Mystery: Next Generation Sequencing Sheds Light on Neuroblastoma Pathogenesis and Targeted Therapies. Frontiers in Bioscience-Landmark. 28(8). 171–171. 2 indexed citations
6.
Mert-Ozupek, Nazli, Gizem Calibasi‐Kocal, Nur Olgun, et al.. (2022). In-silico molecular interactions among the secondary metabolites of Caulerpa spp. and colorectal cancer targets. Frontiers in Chemistry. 10. 1046313–1046313. 5 indexed citations
7.
Olgun, Nur, Dilek İnce, Handan Güleryüz, et al.. (2022). Dinutuximab beta plus conventional chemotherapy for relapsed/refractory high-risk neuroblastoma: A single-center experience. Frontiers in Oncology. 12. 1041443–1041443. 8 indexed citations
8.
Aktaş, Safiye, et al.. (2021). Questioning How to Define the “Ultra-High-Risk” Subgroup of Neuroblastoma Patients. Folia Biologica. 67(1). 1–9. 6 indexed citations
9.
Kudubeş, Aslı Akdeniz, Murat Bektaş, Dilek İnce, & Nur Olgun. (2021). The effect of text message reminders on nausea, vomiting and quality of life in children with cancer receiving cisplatin. Journal of Pediatric Nursing. 64. e109–e118. 1 indexed citations
10.
Olgun, Nur, et al.. (2018). Comparison of Cisplatin with Lipoplatin in Terms of Ototoxicity. The Journal of International Advanced Otology. 14(2). 211–215. 10 indexed citations
11.
Kıray, Müge, Mustafa Kır, Alper Bağrıyanık, et al.. (2016). Protective Effect of Acetyl-L-Carnitine Against Doxorubicin-induced Cardiotoxicity in Wistar Albino Rats. Archives of Medical Research. 47(7). 506–514. 19 indexed citations
12.
Kırkım, Günay, et al.. (2015). Apoptotic Effects of Sanguinarine on the Organ of Corti 1 Cells: Comparison with Cisplatin. The Journal of International Advanced Otology. 11(1). 19–22. 3 indexed citations
13.
Olgun, Nur, et al.. (2013). Kanser Tedavisi Gören Çocuklarda Tedavinin Diş Gelişimine Olan Geç Yan Etkileri (Dört Olgu Sunumu). DergiPark (Istanbul University). 23. 1 indexed citations
14.
İnce, Dilek, Kamer Mutafoğlu, Erdener Özer, et al.. (2011). Soft tissue sarcomas and central nervous system tumors in children with neurofibromatosis type 1. Child s Nervous System. 27(11). 1885–1893. 11 indexed citations
15.
Kırkım, Günay, Enis Alpin Güneri̇, Candan Özoğul, et al.. (2011). Evaluation of the Effect of Acetyl <i>L</i>-Carnitine on Experimental Cisplatin Ototoxicity and Neurotoxicity. Chemotherapy. 57(3). 186–194. 22 indexed citations
16.
Mutafoğlu, Kamer, et al.. (2010). Febrile neutropenic episodes in children with lymphoma and malignant solid tumors. Çocuk Enfeksiyon Dergisi/Journal of Pediatric Infection. 4(1). 1–8. 4 indexed citations
17.
Aktaş, Safiye, et al.. (2009). Expression and Methylation Pattern of p16 in Neuroblastoma Tumorigenesis. Pathology & Oncology Research. 16(1). 1–6. 2 indexed citations
18.
Tüfekçi, Özlem, Candan Özoğul, Zekiye Altun, et al.. (2009). Evaluation of the Effect of Acetyl <i>L</i>-Carnitine on Experimental Cisplatin Nephrotoxicity. Chemotherapy. 55(6). 451–459. 37 indexed citations
19.
Aktaş, Safiye, Aydanur Kargı, Nur Olgun, et al.. (2007). Prognostic Significance of Cell Proliferation and Apoptosis-Regulating Proteins in Epstein-Barr Virus Positive and Negative Pediatric Hodgkin Lymphoma. Lymphatic Research and Biology. 5(3). 175–182. 14 indexed citations
20.
Obuz, Funda, et al.. (2000). MR Imaging of Pancreatic Metastasis from Extraosseous Ewing's Sarcoma. Pancreas. 20(1). 102–104. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Choong Hyun Kim Breakdown of academic impact, for papers by Şeyda Erdoğan Breakdown of academic impact, for papers by Karim Burkhardt Breakdown of academic impact, for papers by Eelke M. Bos Breakdown of academic impact, for papers by Indraneel Banerjee Breakdown of academic impact, for papers by Mario Castellucci Breakdown of academic impact, for papers by Maurizio Guida Breakdown of academic impact, for papers by Louisa Ho Breakdown of academic impact, for papers by Kálmán Kovács Breakdown of academic impact, for papers by Moon Kyu Kim
Rankless by CCL
2026